Bayview Pharmacy's Doxycycline 30 mg Slow Release Capsules, formulated with Methocel E4M, are designed to gradually release the active ingredient over an extended period. This controlled-release mechanism offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance. These capsules are used to treat conditions such as Chlamydia, Lyme Disease, Acne, Malaria, and Rocky Mountain Spotted Fever.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Doxycycline 30 mg Slow Release Capsules is a potent medication used to combat a wide range of bacterial infections. This tetracycline antibiotic functions by inhibiting bacterial growth. It is also utilized as a preventive measure against malaria.
This particular formulation of Doxycycline is compounded with Methocel E4M, a controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism reduces the frequency of dosing and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
The recommended dosage of Doxycycline 30 mg Slow Release Capsules is one capsule taken once daily. It is advised to take the capsule with a full glass of water and accompanied by food or milk to minimize potential stomach upset. It is important to note that antacids or iron supplements should not be taken within two hours of consuming Doxycycline 30 mg Slow Release Capsules.
While Doxycycline 30 mg Slow Release Capsules is generally well-tolerated, some patients may experience side effects such as nausea, vomiting, diarrhea, and abdominal pain. If any of these side effects occur, patients are advised to contact their healthcare provider immediately.
Its long-acting formulation ensures a sustained release of the active ingredient, providing consistent therapeutic effects. If you have any questions or concerns about Doxycycline 30 mg Slow Release Capsules, please do not hesitate to contact us.
Doxycycline 30 mg Slow Release Capsules are a specialized formulation designed to provide a controlled and prolonged release of the active ingredient, doxycycline. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which allows for the gradual release of the medication over an extended period of time. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled release profile.
These capsules are indicated for the treatment of a variety of bacterial infections, including respiratory tract infections, skin and soft tissue infections, and sexually transmitted diseases. They are also used in the treatment of malaria and certain types of urinary tract infections. It is important to note that doxycycline may interact with other medications, including antacids, iron supplements, and certain antibiotics. Therefore, patients should inform their healthcare provider of all medications they are currently taking, including over-the-counter medications, vitamins, and herbal supplements.
Patients should also be aware of potential side effects of doxycycline, which may include photosensitivity. As such, it is recommended to use sunscreen and wear protective clothing when exposed to direct sunlight while taking this medication. Gastrointestinal upset, including nausea, vomiting, and diarrhea, may also occur. If any of these side effects occur, patients should immediately contact their healthcare provider.
If you have any questions about the use of Doxycycline 30 mg Slow Release Capsules, please consult with your healthcare provider or pharmacist.
Doxycycline 30 mg Slow Release Capsules are a specialized oral medication designed to treat a variety of bacterial infections. These include conditions such as acne, urinary tract infections, sexually transmitted diseases, and even malaria. The medication can also be used in conjunction with other drugs to treat certain types of cancer.
The unique formulation of these capsules incorporates Methocel E4M, a controlled-release polymer. This innovative design allows for a gradual release of the encapsulated doxycycline over an extended period. This slow release mechanism ensures a more consistent level of the drug in the body over a longer duration, enhancing the therapeutic effects of the medication.
Such a sustained release profile offers several benefits. It reduces the dosing frequency, thereby improving patient compliance, especially for those on long-term medication. It also minimizes the risk of side effects and enhances the overall effectiveness of the treatment.
When taking Doxycycline 30 mg Slow Release Capsules, it is crucial to follow the prescribed dosage instructions. The capsules should be swallowed whole with a full glass of water and should not be crushed or chewed. Consistency is key, so ensure to take the medication at the same time each day. It is also important to complete the entire course of treatment, even if symptoms improve before the course is finished.
If you have any queries or concerns about taking Doxycycline 30 mg Slow Release Capsules, do not hesitate to seek professional advice. It is essential to understand how to take this medication safely and effectively to ensure the best possible health outcomes.
Doxycycline 30 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the active ingredient over an extended period of time.
The slow release formulation offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance. This is particularly beneficial for medications requiring a controlled and prolonged release profile.
Methocel E4M is a type of controlled-release polymer used in the formulation of certain medications. It is designed to gradually release the encapsulated medication or active ingredient over an extended period of time.
The slow release mechanism works by gradually releasing the active ingredient over an extended period of time. This is achieved through the use of a controlled-release polymer, Methocel E4M, which encapsulates the medication.
Reduced dosing frequency can improve patient compliance, as it is often easier for patients to remember to take their medication when the dosing frequency is lower. It can also reduce the risk of side effects and improve the overall effectiveness of the medication.
The slow release formulation improves patient compliance by reducing the dosing frequency. This makes it easier for patients to remember to take their medication, and can also reduce the risk of side effects.
No, the slow release formulation is not suitable for all medications. It is particularly beneficial for medications requiring a controlled and prolonged release profile.
As with any medication, the slow release formulation can cause side effects. However, the risk of side effects may be reduced due to the gradual release of the active ingredient.
The duration of the slow release formulation can vary depending on the specific medication and the individual patient. However, it is designed to release the active ingredient gradually over an extended period of time.
No, the capsule should not be opened or crushed. This could interfere with the slow release mechanism and could potentially lead to an overdose of the medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth